AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
63 hedge funds and large institutions have $57.7M invested in AVEO Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
22
Reduced
15
Closed
15
Calls
$7.03M
Puts
$5.76M
Net Calls
+$1.27M
Net Calls Change
-$1.52M
Top Buyers
| 1 |
1
BlackRock
New York
|
$9.25M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$1.65M |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$1.36M |
| 4 |
PP
4
PDT Partners
New York
|
$367K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$1.13M |
